Home > Authorities > Periodicals > Expert opinion on investigational drugs > print |
001 | 14181 | ||
005 | 20250112183548.0 | ||
022 | _ | _ | |2 (DE-600)1182884-5 |a 1354-3784 |
022 | _ | _ | |a 1354-3784 |l 1744-7658 |
022 | _ | _ | |a 1744-7658 |
024 | 7 | _ | |2 ZDBID |a PERI:(DE-600)2030114-5 |
024 | 7 | _ | |2 ZDBPPN |a ZDPPN:020990359 |
024 | 7 | _ | |2 EZBID |a PERI:(DE-606)8539 |
024 | 7 | _ | |2 OCLC |a OCLC:1368159265 |
024 | 7 | _ | |2 JCR |a JCR:EXPERT OPIN INV DRUG |
024 | 7 | _ | |2 ISI |a WOS:EXPERT OPINION ON INVESTIGATIONAL DRUGS |
024 | 7 | _ | |2 SCOPUS |a SCOPUS:21351 |
024 | 7 | _ | |2 Medline |a medline:9434197 |
035 | _ | _ | |a PERI:(DE-600)2030114-5 |
040 | _ | _ | |a 0355 |b ger |c DE-101 |d JOIN² |e JOIN² journal identification |
041 | _ | _ | |a eng |
044 | _ | _ | |c XA-GB |
082 | _ | _ | |2 22sdnb |a 610 |q DE-600 |
082 | 7 | 4 | |2 22sdnb |a 610 |q DE-600 |
084 | _ | _ | |2 fid |a PHARM |q DE-84 |
084 | _ | _ | |2 ssgn |a 15,3 |
210 | 0 | _ | |2 DE-600 |a Expert Opin Investig Drugs |
210 | 0 | _ | |2 dnlm |a Expert Opin Investig Drugs |
210 | 0 | _ | |2 iso |a Expert Opin Investig Drugs |
242 | 2 | 0 | |2 DE-600 |a Expert opinion on investigational drugs |b EOID |y en |
242 | 2 | 0 | |2 DE-600 |a Expert opinion on investigational drugs |b EOID |
245 | _ | _ | |2 DE-600 |a Expert opinion on investigational drugs |b EOID |h print, online |
246 | 3 | _ | |2 DE-600 |a Expert opinion on investigational drugs |
246 | 3 | _ | |a Expert opinion on investigational drugs |
246 | 3 | _ | |a EOID |
260 | _ | _ | |a Abingdon, Oxon |b Routledge, Taylor & Francis |c 1994- |
260 | _ | 1 | |0 Host:(DE-Juel1)46 |2 DE-Juel1 |a Taylor & Francis |
264 | 2 | 1 | |3 anfangs |a London [u.a.] |b Informa Healthcare |
264 | 3 | 1 | |a Abingdon, Oxon |b Routledge, Taylor & Francis |c 1994- |
362 | 0 | _ | |2 DE-600 |a Nachgewiesen 3.1994 - |
363 | 0 | 1 | |2 DE-600 |8 1.1\x |a 3 |i 1994 |
380 | _ | _ | |2 marcgt |a journal |
500 | _ | _ | |a Automatically generated record. (Updated: 2024-12-18) |
650 | _ | 7 | |0 ASJC:2736 |2 ASJC |a Pharmacology (medical) |
650 | _ | 7 | |0 ASJC:3004 |2 ASJC |a Pharmacology |
776 | 0 | 8 | |2 DE-600 |d London : Informa Healthcare, 1994- |i Erscheint auch als |n Druck-Ausgabe |t Expert opinion on investigational drugs |w (DE-600)1182884-5 |x 1354-3784 |
856 | 4 | _ | |d 0 |u https://ezb.ur.de/?2030114-5 |y EZB |
856 | 4 | _ | |d 0 |u https://www.tandfonline.com/loi/ieid20 |y Verlag; 3.1994 - 18.2009 = Deutschlandweit zugänglich |
880 | 1 | _ | |2 DE-600 |a Expert opinion on investigational drugs |b EOID |
909 | C | O | |o oai:juser.fz-juelich.de:74187 |p authority:PERI |p authority |
909 | C | O | |o oai:juser.fz-juelich.de:74187 |
915 | _ | _ | |0 StatID:(DE-HGF)0100 |2 StatID |a JCR |b EXPERT OPIN INV DRUG : 2022 |d 2024-12-18 |
915 | _ | _ | |0 StatID:(DE-HGF)0200 |2 StatID |a DBCoverage |b SCOPUS |d 2024-12-18 |
915 | _ | _ | |0 StatID:(DE-HGF)0300 |2 StatID |a DBCoverage |b Medline |d 2024-12-18 |
915 | _ | _ | |0 StatID:(DE-HGF)0199 |2 StatID |a DBCoverage |b Clarivate Analytics Master Journal List |d 2024-12-18 |
915 | _ | _ | |0 StatID:(DE-HGF)1050 |2 StatID |a DBCoverage |b BIOSIS Previews |d 2024-12-18 |
915 | _ | _ | |0 StatID:(DE-HGF)0160 |2 StatID |a DBCoverage |b Essential Science Indicators |d 2024-12-18 |
915 | _ | _ | |0 StatID:(DE-HGF)1030 |2 StatID |a DBCoverage |b Current Contents - Life Sciences |d 2024-12-18 |
915 | _ | _ | |0 StatID:(DE-HGF)1120 |2 StatID |a DBCoverage |b BIOSIS Reviews Reports And Meetings |d 2024-12-18 |
915 | _ | _ | |0 StatID:(DE-HGF)0113 |2 StatID |a WoS |b Science Citation Index Expanded |d 2024-12-18 |
915 | _ | _ | |0 StatID:(DE-HGF)0150 |2 StatID |a DBCoverage |b Web of Science Core Collection |d 2024-12-18 |
915 | _ | _ | |0 StatID:(DE-HGF)9905 |2 StatID |a IF >= 5 |b EXPERT OPIN INV DRUG : 2022 |d 2024-12-18 |
980 | _ | _ | |a PERI |
980 | _ | _ | |a AUTHORITY |
Library | Collection | CLSMajor | CLSMinor | Language | Author |
---|